Inovio Pharmaceuticals INO
NASDAQ INO
$0.84 +0.04 (+5.48%)
At close: Oct 22, 2026 · 4:00 PM EDT

Inovio Pharmaceuticals (INO) Total Debt (2019 - 2023)

Updated

Inovio Pharmaceuticals' Total Debt was $16.77 million in Q4 2023, up 1.7% from the prior quarter.

Analysis

Inovio Pharmaceuticals (INO) Total Debt (2019 - 2023) Analysis & Trends

From Q1 2023 onward, Inovio Pharmaceuticals has reported Total Debt for 4 quarters.

  • Per Business Quant data, INO's Total Debt in the three quarters before Q4 2023 was $16.49 million (Q3 2023), $16.71 million (Q2 2023) and $16.39 million (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 44.65 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 70.82 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 32.35 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 26.25 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 63.19 Bn
10 Inovio Pharmaceuticals 68.68 Mn -114.99 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 16.77 Mn
Sep 30, 2023 16.49 Mn
Jun 30, 2023 16.71 Mn
Mar 31, 2023 16.39 Mn
Jun 30, 2019 62.76 Mn
Mar 31, 2019 60.56 Mn
API Access

Inovio Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=INO&period=max&api_key=YOUR_API_KEY